Cargando…
Anti-nucleolin aptamer AS1411: an advancing therapeutic
Targeted therapy is highly desirable, as it allows for selective cytotoxicity on diseased cells without off-target side effects. Nucleolin is a remarkable target for cancer therapy given its high abundance, selective presence on the plasma membrane, and multifaceted influence on the initiation and p...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10551449/ https://www.ncbi.nlm.nih.gov/pubmed/37808518 http://dx.doi.org/10.3389/fmolb.2023.1217769 |